LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Esther Grunis, IBCLC" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 14 Nov 2007 09:53:14 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (41 lines)
I got this from this week's FDA digest:

 

UPCOMING PUBLIC MEETINGS 

 

Nov. 27-29 -- Pediatric Advisory Committee

    Under discussion: adverse event reports related to the drug Tamiflu
(Nov. 27-28); labeling of drugs for lactating women (Nov. 29)

    Location: Gaithersburg, Md.

>  Nov. 27-28: http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-20302.htm

>  Nov. 29: http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-20304.htm

 

 

 

Esther G

 


             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2